{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:33:57Z","timestamp":1762522437237,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:00:00Z","timestamp":1588982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:00:00Z","timestamp":1588982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Europen Union and the Hungarian Government","award":["EFOP-3.6.2-16-2017-00009"],"award-info":[{"award-number":["EFOP-3.6.2-16-2017-00009"]}]},{"name":"H2020 HCEMM","award":["739593"],"award-info":[{"award-number":["739593"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s13555-020-00385-9","type":"journal-article","created":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T03:34:25Z","timestamp":1588995265000},"page":"651-662","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Randomized Controlled Trial with a Medical Device Containing Sodium Hyaluronate and Nicotinic Acid to Increase the Efficacy of Ultraviolet Phototherapy in Psoriasis"],"prefix":"10.1007","volume":"10","author":[{"given":"Bal\u00e1zs","family":"Bende","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00f3bert","family":"Kui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annam\u00e1ria","family":"N\u00e9meth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariann","family":"Borsos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n","family":"T\u00f3bi\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5945-0370","authenticated-orcid":false,"given":"G\u00e1bor","family":"Er\u0151s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lajos","family":"Kem\u00e9ny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eszter","family":"Balt\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,9]]},"reference":[{"key":"385_CR1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","volume":"133","author":"R Parisi","year":"2013","unstructured":"Parisi R, Symmons DP, Griffiths CE, Aschroft DM. Global epidemiology of psoriasis: a systemic review of incidence and prevalence. J Invest Dermatol. 2013;133:377\u201385.","journal-title":"J Invest Dermatol"},{"key":"385_CR2","first-page":"278","volume":"63","author":"WB Kim","year":"2017","unstructured":"Kim WB, Jerome D, Yeung J. Diagnosis and management of psoriasis. Can Fam Phys. 2017;63:278\u201385.","journal-title":"Can Fam Phys"},{"key":"385_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1046\/j.1365-4362.2000.00878.x","volume":"39","author":"SR Feldman","year":"2000","unstructured":"Feldman SR, Fleischer AB Jr, Cooper JZ. New topical treatments change the pattern of treatment of psoriasis: dermatologists remain the primary providers of this care. Int J Dermatol. 2000;39:41\u20134.","journal-title":"Int J Dermatol"},{"key":"385_CR4","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jaad.2007.06.042","volume":"57","author":"EJ Horn","year":"2007","unstructured":"Horn EJ, Fox KM, Patel V, Chiou CF, Dann F, Lebwohl M. Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey. J Am Acad Dermatol. 2007;57:957\u201362.","journal-title":"J Am Acad Dermatol"},{"key":"385_CR5","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jaad.2008.12.032","volume":"60","author":"A Menter","year":"2009","unstructured":"Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol. 2009;60:643\u201359.","journal-title":"J Am Acad Dermatol"},{"key":"385_CR6","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1136\/bmj.320.7240.963","volume":"320","author":"DM Ashcroft","year":"2000","unstructured":"Ashcroft DM, Po AL, Williams HC, Griffith CE. Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis. BMJ. 2000;320:963\u20137.","journal-title":"BMJ"},{"key":"385_CR7","doi-asserted-by":"crossref","unstructured":"Mason AR, Mason J, Cork M, Dooley G, Edwards G. Topical treatments for chronic plaque psoriasis. Cochrane Database Syst Rev. 2009;(2): CD005028.","DOI":"10.1002\/14651858.CD005028.pub2"},{"key":"385_CR8","first-page":"25","volume":"9","author":"G Goldenberg","year":"2016","unstructured":"Goldenberg G, Lanoue J, Dong J. New oral therapies for psoriasis: a comprehensive review. J Clin Aesthet Dermatol. 2016;9:25\u20138.","journal-title":"J Clin Aesthet Dermatol"},{"key":"385_CR9","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1001\/2013.jamadermatol.238","volume":"148","author":"VW Lin","year":"2012","unstructured":"Lin VW, Ringold S, Devine EB. Comparison of ustekinumab with other biological agents for the treatment of moderate to severe plaque psoriasis: a Bayesian network meta-analysis. Arch Dermatol. 2012;148:1403\u201310.","journal-title":"Arch Dermatol"},{"key":"385_CR10","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.jaad.2008.02.039","volume":"58","author":"A Menter","year":"2008","unstructured":"Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58:826\u201350.","journal-title":"J Am Acad Dermatol"},{"key":"385_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10103-017-2360-1","volume":"33","author":"P Zhang","year":"2018","unstructured":"Zhang P, Wu MX. A clinical review of phototherapy for psoriasis. Lasers Med Sci. 2018;33:173\u201380.","journal-title":"Lasers Med Sci"},{"key":"385_CR12","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/S0140-6736(05)63945-1","volume":"350","author":"B B\u00f3nis","year":"1997","unstructured":"B\u00f3nis B, Kem\u00e9ny L, Dobozy A, Bor Z, Szab\u00f3 G, Ign\u00e1cz F. 308 nm UVB excimer laser for psoriasis. Lancet. 1997;350:1522.","journal-title":"Lancet"},{"key":"385_CR13","first-page":"95","volume":"137","author":"L Kem\u00e9ny","year":"2001","unstructured":"Kem\u00e9ny L, B\u00f3nis B, Dobozy A, Bor Z, Szab\u00f3 G, Ign\u00e1cz F. 308-nm excimer laser therapy for psoriasis. Arch Dermatol. 2001;137:95\u20136.","journal-title":"Arch Dermatol"},{"key":"385_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S1011-1344(02)00280-4","volume":"67","author":"Z Nov\u00e1k","year":"2002","unstructured":"Nov\u00e1k Z, B\u00f3nis B, Balt\u00e1s E, et al. Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrow-band ultraviolet B. J Photochem Photobiol B. 2002;67:32\u20138.","journal-title":"J Photochem Photobiol B"},{"key":"385_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1600-0781.2006.00221.x","volume":"22","author":"E Fetil","year":"2006","unstructured":"Fetil E, Akarsu S, Ilknur T, Kusku E, G\u00fcnes AT. Effects of some emollients on the transmission of ultraviolet. Photodermatol Photoimmunol Photomed. 2006;22:137\u201340.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"385_CR16","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/j.1365-2133.2006.07171.x","volume":"154","author":"SG Otman","year":"2006","unstructured":"Otman SG, Edwards C, Pearse AD, Gambles BJ, Anstey AV. Modulation of ultraviolet (UV) transmission by emollients: relevance to narrowband UVB phototherapy and psoralen plus UVA photochemotherapy. Br J Dermatol. 2006;154:963\u20138.","journal-title":"Br J Dermatol"},{"key":"385_CR17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1525-1470.2008.00729.x","volume":"25","author":"VK Jain","year":"2008","unstructured":"Jain VK, Bansal A, Aggarwal K, Jain K. Enhanced response of childhood psoriasis to narrow-band UV-B phototherapy with preirradiation use of mineral oil. Pediatr Dermatol. 2008;25:559\u201364.","journal-title":"Pediatr Dermatol"},{"key":"385_CR18","first-page":"1371","volume":"36","author":"C Seebode","year":"2016","unstructured":"Seebode C, Lehmann J, Emmert S. Photocarcinogenesis and skin cancer prevention strategies. Anticancer Res. 2016;36:1371\u20138.","journal-title":"Anticancer Res"},{"key":"385_CR19","first-page":"195","volume":"19","author":"N Ben\u00e1kov\u00e1","year":"2011","unstructured":"Ben\u00e1kov\u00e1 N. Phototherapy of psoriasis in the era of biologics: still in. Acta Dermatovenerol Croat. 2011;19:195\u2013205.","journal-title":"Acta Dermatovenerol Croat"},{"key":"385_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00403-010-1080-1","volume":"303","author":"U Mrowietz","year":"2011","unstructured":"Mrowietz U, Kragballe K, Reich K, et al. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res. 2011;303:1\u201310.","journal-title":"Arch Dermatol Res"},{"key":"385_CR21","doi-asserted-by":"publisher","first-page":"e6712","DOI":"10.1136\/bmj.e6712","volume":"345","author":"E Samarasekera","year":"2012","unstructured":"Samarasekera E, Sawyer L, Parnham J, Smith CH. Assessment and management of psoriasis: summary of NICE guidance. BMJ. 2012;345:e6712.","journal-title":"BMJ"},{"key":"385_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s000110050282","volume":"47","author":"J Warnecke","year":"1998","unstructured":"Warnecke J, Wendt A. Antiinflammatory action of pale sulfonated shale oil in UVB erythema test. Inflamm Res. 1998;47:75\u20138.","journal-title":"Inflamm Res"},{"key":"385_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/1523-1747.ep12479191","volume":"77","author":"RR Anderson","year":"1981","unstructured":"Anderson RR, Parrish JA. The optics of human skin. J Invest Dermatol. 1981;77:13\u20139.","journal-title":"J Invest Dermatol"},{"key":"385_CR24","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1001\/archderm.143.5.647","volume":"143","author":"T Gambichler","year":"2007","unstructured":"Gambichler T. Balneophototherapy for psoriasis saltwater baths and UV-B irradiation, revisited. Arch Dermatol. 2007;143:647\u20139.","journal-title":"Arch Dermatol"},{"key":"385_CR25","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jaad.2018.03.018","volume":"79","author":"SY Tan","year":"2018","unstructured":"Tan SY, Buzney E, Mostaghimi A. Trends in phototherapy utilization among Medicare beneficiaries in the United States, 2000 to 2015. J Am Acad Dermatol. 2018;79:672\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"385_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1365-2133.1994.tb02934.x","volume":"130","author":"MJ Hudson-Peacock","year":"1994","unstructured":"Hudson-Peacock MJ, Diffey BL, Farr PM. Photoprotective action of emollients in ultraviolet therapy of psoriasis. Br J Dermatol. 1994;130:361\u20135.","journal-title":"Br J Dermatol"},{"key":"385_CR27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/0190-9622(95)90071-3","volume":"32","author":"M Lebwohl","year":"1995","unstructured":"Lebwohl M, Martinez J, Weber P, DeLuca R. Effects of topical preparations on the erythemogenicity of UVB: implications for psoriasis phototherapy. J Am Acad Dermatol. 1995;32:469\u201371.","journal-title":"J Am Acad Dermatol"},{"key":"385_CR28","unstructured":"Kem\u00e9ny L, R\u00e9v\u00e9sz P, Cs\u00e1nyi E. Composition for increasing of the effectiveness of UV-B therapy, process for the preparation thereof, and its use. Patent No.: US9839595. Alexandria: US Patent and Trademark Office."},{"key":"385_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.5487\/TR.2015.31.2.105","volume":"31","author":"HJ Jang","year":"2015","unstructured":"Jang HJ, Shin CY, Kim KB. Safety evaluation of polyethylene glycol (PEG) compounds for cosmetic use. Toxicol Res. 2015;31:105\u201336.","journal-title":"Toxicol Res"},{"key":"385_CR30","unstructured":"DRUGBANK. https:\/\/www.drugbank.ca\/drugs\/DB00627."},{"key":"385_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/1091581809337738","volume":"28","author":"LC Becker","year":"2009","unstructured":"Becker LC, Bergfeld WF, Belsito DV, et al. Final report of the safety assessment of hyaluronic acid, potassium hyaluronate, and sodium hyaluronate. Int J Toxicol. 2009;28:5\u201367.","journal-title":"Int J Toxicol"},{"key":"385_CR32","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1600-0781.2009.00443.x","volume":"25","author":"LT Nilsen","year":"2009","unstructured":"Nilsen LT, Soyland E, Krogstad AL. Estimated ultraviolet doses to psoriasis patients during climate therapy. Photodermatol Photoimmunol Photomed. 2009;25:202\u20138.","journal-title":"Photodermatol Photoimmunol Photomed"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-020-00385-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-020-00385-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-020-00385-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T12:08:44Z","timestamp":1710504524000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-020-00385-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,9]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["385"],"URL":"https:\/\/doi.org\/10.1007\/s13555-020-00385-9","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"type":"print","value":"2193-8210"},{"type":"electronic","value":"2190-9172"}],"subject":[],"published":{"date-parts":[[2020,5,9]]},"assertion":[{"value":"1 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}